Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

macure healthcare limited - lorazepam - tabletter - 0,5 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

macure healthcare limited - lorazepam - tabletter - 1 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

macure healthcare limited - lorazepam - tabletter - 2,5 mg

Danmark - dansk - Ecolab

ecolab deutschland gmbh -

Den Europæiske Union - dansk - EMA (European Medicines Agency)

novartis europharm limited - brinzolamid - glaucoma, open-angle; ocular hypertension - oftalmologiske - azopt er angivet til at sænke forhøjet intraokulært tryk i:okulær hypertension, åbenvinklet glaucomaas monoterapi hos voksne patienter, som ikke reagerer på beta-blokkere eller i voksne patienter, hos hvem beta-blokkere er kontraindiceret, eller som supplerende terapi til at beta-blokkere eller prostaglandin-analoger.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

janssen-cilag international n.v. - paliperidonpalmitat - skizofreni - psykoleptika - xeplion er indiceret til vedligeholdelsesbehandling af skizofreni hos voksne patienter stabiliseret med paliperidon eller risperidon. in selected adult patients with schizophrenia and previous responsiveness to oral paliperidone or risperidone, xeplion may be used without prior stabilisation with oral treatment if psychotic symptoms are mild to moderate and a long-acting injectable treatment is needed.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

novartis europharm limited - brinzolamid, timolol maleate - glaucoma, open-angle; ocular hypertension - oftalmologiske - reduktion af intraokulært tryk (iop) hos voksne patienter med åbenvinklet glaukom eller okulær hypertension, for hvem monoterapi giver utilstrækkelig iop reduktion.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

janssen-cilag international nv - paliperidonpalmitat - skizofreni - psykoleptika - trevicta, en 3 månedlig injektion, er indiceret til vedligeholdelsesbehandling af skizofreni hos voksne patienter, der er klinisk stabile på 1 månedligt injicerbart paliperidonpalmitatprodukt.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

janssen-cilag international n.v.   - paliperidonpalmitat - skizofreni - psykoleptika - byannli (previously paliperidone janssen-cilag international) a 6 monthly injection, is indicated for the maintenance treatment of schizophrenia in adult patients who are clinically stable on 1 monthly or 3 monthly paliperidone palmitate injectable products (see section 5.

Den Europæiske Union - dansk - EMA (European Medicines Agency)

novartis europharm limited - eltrombopag - purpura, trombocytopenisk, idiopatisk - other systemic hemostatics, antihemorrhagics - revolade is indicated for the treatment of adult patients with primary immune thrombocytopenia (itp) who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 og 5. revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia (itp) lasting 6 months or longer from diagnosis and who are refractory to other treatments (e. corticosteroids, immunoglobulins) (see sections 4. 2 og 5. revolade is indicated in adult patients with chronic hepatitis c virus (hcv) infection for the treatment of thrombocytopenia, where the degree of thrombocytopenia is the main factor preventing the initiation or limiting the ability to maintain optimal interferon-based therapy (see sections 4. 4 and 5. revolade is indicated in adult patients with acquired severe aplastic anaemia (saa) who were either refractory to prior immunosuppressive therapy or heavily pretreated and are unsuitable for haematopoietic stem cell transplantation (see section 5.